Benjamin M. Beckermann

1.1k total citations
10 papers, 735 citations indexed

About

Benjamin M. Beckermann is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Benjamin M. Beckermann has authored 10 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Hematology and 3 papers in Genetics. Recurrent topics in Benjamin M. Beckermann's work include Hemophilia Treatment and Research (3 papers), Cancer Cells and Metastasis (3 papers) and Acute Myeloid Leukemia Research (2 papers). Benjamin M. Beckermann is often cited by papers focused on Hemophilia Treatment and Research (3 papers), Cancer Cells and Metastasis (3 papers) and Acute Myeloid Leukemia Research (2 papers). Benjamin M. Beckermann collaborates with scholars based in Germany, Switzerland and France. Benjamin M. Beckermann's co-authors include Georgios Kallifatidis, Ingrid Herr, Markus W. Büchler, Gerhard Moldenhauer, J Mattern, A Apel, A. V. Salnikov, Peter Büchler, David Frommhold and Wolfgang Wagner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gut.

In The Last Decade

Benjamin M. Beckermann

10 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin M. Beckermann Germany 7 340 303 224 145 90 10 735
Khadijeh Bijangi‐Vishehsaraei United States 14 453 1.3× 238 0.8× 141 0.6× 162 1.1× 61 0.7× 29 732
Guanqun Ge China 14 383 1.1× 195 0.6× 299 1.3× 198 1.4× 172 1.9× 28 906
Shibing Yu United States 17 601 1.8× 275 0.9× 61 0.3× 114 0.8× 71 0.8× 25 965
Su-Peng Yeh Taiwan 13 533 1.6× 139 0.5× 97 0.4× 213 1.5× 58 0.6× 29 856
Brandi Bailey United States 12 602 1.8× 222 0.7× 230 1.0× 67 0.5× 275 3.1× 20 1.1k
Françoise Fauvel-Lafève France 15 346 1.0× 151 0.5× 64 0.3× 155 1.1× 83 0.9× 23 709
Riccardo Bazzoni Italy 12 416 1.2× 107 0.4× 210 0.9× 203 1.4× 35 0.4× 18 618
Mariella Patti Italy 6 314 0.9× 174 0.6× 118 0.5× 81 0.6× 93 1.0× 6 556
Sandra Hermann Germany 15 310 0.9× 181 0.6× 96 0.4× 35 0.2× 103 1.1× 40 752
Sateesh Kunigal United States 10 290 0.9× 153 0.5× 102 0.5× 123 0.8× 45 0.5× 19 567

Countries citing papers authored by Benjamin M. Beckermann

Since Specialization
Citations

This map shows the geographic impact of Benjamin M. Beckermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin M. Beckermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin M. Beckermann more than expected).

Fields of papers citing papers by Benjamin M. Beckermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin M. Beckermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin M. Beckermann. The network helps show where Benjamin M. Beckermann may publish in the future.

Co-authorship network of co-authors of Benjamin M. Beckermann

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin M. Beckermann. A scholar is included among the top collaborators of Benjamin M. Beckermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin M. Beckermann. Benjamin M. Beckermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hermans, Cédric, Samya Obaji, Benjamin M. Beckermann, et al.. (2023). Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis. Research and Practice in Thrombosis and Haemostasis. 7(8). 102239–102239. 1 indexed citations
2.
Négrier, Claude, Johnny Mahlangu, Michaela Lehle, et al.. (2023). Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. The Lancet Haematology. 10(3). e168–e177. 45 indexed citations
3.
Négrier, Claude, Johnny Mahlangu, Michaela Lehle, et al.. (2021). Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study. Blood. 138(Supplement 1). 343–343. 7 indexed citations
4.
Montesinos, Pau, Benjamin M. Beckermann, Olivier Catalani, et al.. (2020). MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia. Future Oncology. 16(13). 807–815. 57 indexed citations
5.
6.
Barrios, Carlos H., David Cella, Miguel Martín, et al.. (2016). Patient-reported outcomes (PROs) from MARIANNE: A phase III study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab + taxane (HT) for HER2-positive advanced breast cancer.. Journal of Clinical Oncology. 34(15_suppl). 593–593. 1 indexed citations
7.
Salnikov, Alexei V., Anja Apel, Georgios Kallifatidis, et al.. (2009). Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma. Journal of Cellular and Molecular Medicine. 13(9b). 4023–4033. 37 indexed citations
8.
Beckermann, Benjamin M., Georgios Kallifatidis, Anja Groth, et al.. (2008). VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. British Journal of Cancer. 99(4). 622–631. 330 indexed citations
9.
Kallifatidis, Georgios, Vanessa Rausch, Bernd Baumann, et al.. (2008). Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling. Gut. 58(7). 949–963. 182 indexed citations
10.
Zhang, Chengwen, Benjamin M. Beckermann, Georgios Kallifatidis, et al.. (2006). Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma. International Journal of Oncology. 29(5). 1295–301. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026